Nearly 23 million U.S. adults with blood pressure readings of 130/80 mm Hg or higher may qualify for blood-pressure-lowering medications under updated clinical recommendations, according to independent research published in the Journal of the American Heart Association. The findings highlight a substantial treatment gap, as over 40% of patients who meet the updated criteria currently … Read more
Patients undergoing hemodialysis with blood type A show a lower risk of cardiovascular mortality compared to other blood types, according to a recent study published in Kidney International Reports. While blood type O is generally linked to lower cardiovascular risk in the broader population, research led by Dr. Masafumi Kurajoh at Osaka Metropolitan University indicates … Read more
Stanford Medicine researchers have identified a primary driver of biological aging: the failure of tissue-resident macrophages to clear senescent, or “zombie,” neutrophils from the body. According to a study published July 16 in Science, blocking a specific pro-inflammatory receptor, EP2, on these immune cells rejuvenated organ function and reduced age-related frailty in mice. This discovery … Read more
Regularly sleeping nine to 10 hours or more per night is linked to higher levels of p-tau181, a blood-based protein marker for Alzheimer’s disease, according to a study from UT Health San Antonio. Researchers found that the association becomes most pronounced beyond 10 hours of sleep, suggesting long sleep may be an early indicator of … Read more
The updated ABCs of cardiovascular disease (CVD) prevention framework, published in the American Journal of Preventive Cardiology in 2026, provides a standardized, evidence-based roadmap for clinicians to manage heart health across a patient’s lifespan. By integrating tools like the PREVENT™ risk scoring system and addressing Cardiovascular-Kidney-Metabolic (CKM) syndrome, the framework shifts clinical focus toward early, … Read more
Solid-organ transplant recipients face a significantly higher risk of mortality if they develop diabetes, according to a comprehensive analysis presented at ENDO 2026, the Endocrine Society’s annual meeting. Researchers analyzed data from over 800,000 U.S. patients who underwent transplants between 2003 and 2021, finding that both pre-existing and post-surgery diabetes consistently reduced long-term survival rates … Read more
Research published in the journal Annals of Oncology indicates that GLP-1 receptor agonists (GLP-1 RAs) are associated with a 41% reduction in overall cancer risk among obese, non-diabetic adults. This study of more than 229,000 patients suggests these medications may offer significant benefits for cancer prevention beyond simple weight management. Which cancers are linked to … Read more
Targeting Aging: A New Frontier in Treating Chronic Renal Failure Chronic renal failure (CRF) remains a formidable medical challenge, marked by a progressive, irreversible decline in kidney function. As current therapeutic options often fall short of halting disease progression, researchers are increasingly looking toward the biological mechanisms of aging as a potential pathway for intervention. … Read more
Rethinking Blood Pressure Management in Diabetic Kidney Disease For millions of people living with type 2 diabetes (T2D), managing blood pressure is a critical, daily necessity. High blood pressure acts as a silent accelerator for diabetic kidney disease (DKD), a condition that gradually compromises the kidneys’ ability to filter waste from the blood. However, recent … Read more
Revolutionizing Kidney Disease Diagnosis: New Study Validates Diagnostic Thresholds and Highlights Combined Testing Benefits Recent research from Karolinska Institutet and Leiden University Medical Center has reaffirmed the clinical relevance of current diagnostic thresholds for chronic kidney disease (CKD), while emphasizing the advantages of combining two blood tests to improve risk assessment. The findings, published in … Read more